リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations

馬場 隆太 広島大学

2022.03.23

概要

Cushing’s syndrome is classified as adrenocorticotropic hormone
(ACTH)-independent or ACTH-dependent cortisol overproduction.
ACTH-independent Cushing’s syndrome is most often due to a unilateral
cortisol-producing adenoma. Cortisol excess leads to Cushingoid fea­
tures such as central obesity, moon face, purple striae, buffalo hump and
others. Patients with Cushing’s syndrome often present with diabetes
mellitus, hypertension, atherosclerosis, osteoporosis and mental disor­
ders (Newell-Price et al., 2006,Nieman et al., 2008).
The etiology of isolated adrenal cortisol-producing adenoma (CPA)
has long remained unclear, but recent studies have demonstrated that
many harbors somatic mutations in PRKACA, GNAS, or CTNNB1
(Beuschlein et al., 2014,Calebiro et al., 2014,Cao et al., 2014,Goh et al.,
2014,Sato et al., 2014). The PRKACA is the most commonly somatic
mutated gene, and occurring in 35–65% of CPA (Beuschlein, 2014,Thiel
et al., 2015,Zhou et al., 2016). ...

この論文で使われている画像

参考文献

Aumo, L., Rusten, M., Mellgren, G., Bakke, M., Lewis, A.E., 2010. Functional roles of

protein kinase A (PKA) and exchange protein directly activated by 3’,5’-cyclic

adenosine 5’-monophosphate (cAMP) 2 (EPAC2) in cAMP-mediated actions in

adrenocortical cells. Endocrinology 151, 2151–2161.

Baba, R., Oki, K., Kobuke, K., Itcho, K., Okubo, H., Ohno, H., Yoneda, M., Hattori, N.,

2018. Measurement of midnight ACTH levels is useful for the evaluation of midnight

cortisol levels. Steroids 140, 179–184.

Beuschlein, F., Fassnacht, M., Assie, G., Calebiro, D., Stratakis, C.A., Osswald, A.,

Ronchi, C.L., Wieland, T., Sbiera, S., Faucz, F.R., Schaak, K., Schmittfull, A.,

Schwarzmayr, T., Barreau, O., Vezzosi, D., Rizk-Rabin, M., Zabel, U., Szarek, E.,

Salpea, P., Forlino, A., Vetro, A., Zuffardi, O., Kisker, C., Diener, S., Meitinger, T.,

Lohse, M.J., Reincke, M., Bertherat, J., Strom, T.M., Allolio, B., 2014. Constitutive

activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N. Engl. J. Med.

370, 1019–1028.

Calebiro, D., Bathon, K., Weigand, I., 2017. Mechanisms of Aberrant PKA activation by

calpha subunit mutations. Horm. Metab. Res. 49, 307–314.

Calebiro, D., Hannawacker, A., Lyga, S., Bathon, K., Zabel, U., Ronchi, C., Beuschlein, F.,

Reincke, M., Lorenz, K., Allolio, B., Kisker, C., Fassnacht, M., Lohse, M.J., 2014. PKA

catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association

with the regulatory subunit. Nat. Commun. 5, 5680.

Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., Zhou, W., Li, X., Zhong, X., Lei, Y., Su, T.,

Wang, H., Jiang, Y., Yang, L., Wei, W., Yang, X., Jiang, X., Liu, L., He, J., Ye, J.,

Wei, Q., Li, Y., Wang, W., Wang, J., Ning, G., 2014. Activating hotspot L205R

mutation in PRKACA and adrenal Cushing’s syndrome. Science 344, 913–917.

Di Dalmazi, G., Altieri, B., Scholz, C., Sbiera, S., Luconi, M., Waldman, J., Kastelan, D.,

Ceccato, F., Chiodini, I., Arnaldi, G., Riester, A., Osswald, A., Beuschlein, F.,

Sauer, S., Fassnacht, M., Appenzeller, S., Ronchi, C.L., 2020. RNA sequencing and

somatic mutation status of adrenocortical tumors: novel pathogenetic insights.

J. Clin. Endocrinol. Metab. 105.

Di Dalmazi, G., Kisker, C., Calebiro, D., Mannelli, M., Canu, L., Arnaldi, G., Quinkler, M.,

Rayes, N., Tabarin, A., Laure Jullie, M., Mantero, F., Rubin, B., Waldmann, J.,

Bartsch, D.K., Pasquali, R., Lohse, M., Allolio, B., Fassnacht, M., Beuschlein, F.,

Reincke, M., 2014. Novel somatic mutations in the catalytic subunit of the protein

kinase A as a cause of adrenal Cushing’s syndrome: a European multicentric study.

J. Clin. Endocrinol. Metab. 99, E2093–E2100.

Gao, X., Yamazaki, Y., Tezuka, Y., Pieroni, J., Ishii, K., Atsumi, N., Ono, Y., Omata, K.,

Morimoto, R., Nakamura, Y., Satoh, F., Sasano, H., 2020. Intratumoral heterogeneity

of the tumor cells based on in situ cortisol excess in cortisol-producing adenomas;

approximately an association among morphometry, genotype and cellular

senescence approximately. J. Steroid Biochem. Mol. Biol. 204, 105764.

Goh, G., Scholl, U.I., Healy, J.M., Choi, M., Prasad, M.L., Nelson-Williams, C.,

Kunstman, J.W., Korah, R., Suttorp, A.C., Dietrich, D., Haase, M., Willenberg, H.S.,

Stalberg, P., Hellman, P., Akerstrom, G., Bjorklund, P., Carling, T., Lifton, R.P., 2014.

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat.

Genet. 46, 613–617.

Gomez-Sanchez, C.E., Qi, X., Velarde-Miranda, C., Plonczynski, M.W., Parker, C.R.,

Rainey, W., Satoh, F., Maekawa, T., Nakamura, Y., Sasano, H., Gomez-Sanchez, E.P.,

2014. Development of monoclonal antibodies against human CYP11B1 and

CYP11B2. Mol. Cell. Endocrinol. 383, 111–117.

R. Baba et al.

Molecular and Cellular Endocrinology 538 (2021) 111456

expression of the protein kinase A subunits in normal adrenal glands and

adrenocortical adenomas. Sci. Rep. 7, 49.

Weigand, I., Ronchi, C.L., Vanselow, J.T., Bathon, K., Lenz, K., Herterich, S.,

Schlosser, A., Kroiss, M., Fassnacht, M., Calebiro, D., Sbiera, S., 2021. PKA Calpha

subunit mutation triggers caspase-dependent RIIbeta subunit degradation via Ser

(114) phosphorylation. Sci Adv 7.

Zhou, W., Wu, L., Xie, J., Su, T., Jiang, L., Jiang, Y., Cao, Y., Liu, J., Ning, G., Wang, W.,

2016. Steroidogenic Acute regulatory protein overexpression correlates with protein

kinase A activation in adrenocortical adenoma. PloS One 11, e0162606.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る